Company / Operating Cash Flow
NP Life Sciences Health Industry Group Inc. Operating Cash Flow History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$73.6K
FY2023
5-year range
-$124.3K / $93.9K
FY2019-FY2023
Trend
-178.4%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$90,625 to -$73,607 over the past 2 years.
Based on SEC 10-K filings.
-$73,607 in FY2023.
Improved from -$90,625 to -$73,607 over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, operating cash flow decreased 178.4% year-over-year.
- Peak operating cash flow was recorded in FY2022.
- Lowest operating cash flow in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -1.61 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$73.6K | -178.4% |
| FY2022 | $93.9K | +203.6% |
| FY2021 | -$90.6K | +27.1% |
| FY2020 | -$124.3K | -2814.3% |
| FY2019 | -$4.3K | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026